<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="2-part\PMC6989424\results\search\tropicalVirus\results.xml">
  <result pre="10.3389/fimmu.2020.00016 : Immunology: Original Research CD4 T Cell Determinants in" exact="West Nile" post="Virus Disease and Asymptomatic Infection KoblischkeMaximilian1SpitzerFelicia S.1FlorianDavid M.1AberleStephan W.1MalafaStefan1FaeIngrid2CassanitiIrene34JungbauerChristof5KnappBernhard6LaferlHermann7FischerGottfried2BaldantiFausto34StiasnyKarin1HeinzFranz"/>
  <result pre="is permitted which does not comply with these terms. Abstract" exact="West Nile" post="(WN) virus infection of humans is frequently asymptomatic, but"/>
  <result pre="targeted in other mosquito-borne flaviviruses, including dengue, yellow fever, and" exact="Zika" post="viruses. Together, these findings indicate a strong impact of"/>
  <result pre="is an important issue to consider in future vaccine design." exact="West Nile" post="virus flavivirus CD4 T cell immunodominance epitope West Nile"/>
  <result pre="design. West Nile virus flavivirus CD4 T cell immunodominance epitope" exact="West Nile" post="patients Funding Austrian Science Fund10.13039/501100002428P29881-B30 fig-count: table-count: equation-count: ref-count:"/>
  <result pre="Austrian Science Fund10.13039/501100002428P29881-B30 fig-count: table-count: equation-count: ref-count: page-count: word-count: Introduction" exact="West Nile" post="(WN) virus is a mosquito-borne flavivirus that has caused"/>
  <result pre="virus infection. By measuring responses in 29 individuals with either" exact="West Nile" post="virus disease (WND) or asymptomatic infection, we identified 67"/>
  <result pre="San Matteo Pavia) in northern Italy. Table 1 Characteristics of" exact="West Nile" post="virus-infected subjects. Diagnosis of WNV infection IL-2 ELISPOT result"/>
  <result pre="Table 1 Characteristics of West Nile virus-infected subjects. Diagnosis of" exact="WNV" post="infection IL-2 ELISPOT result Patient Symptoms WNV RNAa WNVIgM"/>
  <result pre="subjects. Diagnosis of WNV infection IL-2 ELISPOT result Patient Symptoms" exact="WNV" post="RNAa WNVIgM E prM C 501 Asymptomatic pos Pos"/>
  <result pre="the time of diagnosis, all 29 participants were negative in" exact="Zika" post="neutralization tests. In addition, previous DEN virus infection was"/>
  <result pre="accordance with biosecurity regulations and institutional safety procedures. Detection of" exact="West Nile" post="Virus RNA WN virus PCR was performed as described"/>
  <result pre="conserved WN virus 3′-noncoding region was used (32). Detection of" exact="West Nile" post="Virus IgM WN virus-specific IgM antibodies were detected in"/>
  <result pre="virus-induced cytopathic effects. Virus NT titers ≥20 were considered positive." exact="Zika" post="virus-specific neutralizing antibodies were determined in Vero cells (23)."/>
  <result pre="dilutions of heat-inactivated serum samples were incubated with 30–60 TCID50" exact="Zika" post="virus (strain H/PF 2013) for 1 h at 37°C."/>
  <result pre="of experimentally identified epitopes were KUN virus C (PDB 1SFK)," exact="Zika" post="sE (5LBV) (26), DEN-2 sE (PDB 1OAN) (27), and"/>
  <result pre="of C and E, multiple sequence alignments were performed (GenBank:" exact="Zika" post="virus KJ776791; DEN 1–4 viruses AF226687, M29095, DQ863638, GQ398256;"/>
  <result pre="of the WN virus (PDB 2I69), YF virus (PDB 6EPK)," exact="Zika" post="virus (PDB 5LBV), and DEN virus sE proteins (PDB"/>
  <result pre="II (E245), or III (E381), respectively onto those of YF," exact="Zika" post="and DEN viruses was performed using the PyMOL algorithms"/>
  <result pre="C protein (PDB 1SFK) (36) highlighting epitopes recognized in WN," exact="Zika" post="(23), DEN (40, 41), and YF viruses (22). (B)"/>
  <result pre="(B) Envelope protein structure alignment of WN (PDB 2I69) (25)," exact="Zika" post="(PDB 5LBV) (26), DEN (PDB 1OAN) (27), and YF"/>
  <result pre="of WN virus sE protein domains with those of YF," exact="Zika" post="and DEN viruses, respectively. The analysis included epitope regions"/>
  <result pre="the upper part of E DI, which is absent in" exact="Zika" post="and DEN viruses (Figure 4). It is notable that"/>
  <result pre="WN virus (PDB 2I69) (25) and YF (PDB 6EPK) (28)," exact="Zika" post="(PDB 5LBV) (26), or DEN (PDB 1OAN) (27) viruses."/>
  <result pre="Figure 5 Peptide-MHC II Binding Prediction and HLA Association of" exact="West Nile" post="Virus Epitopes. (A) Predicted IC50 values for experimentally tested"/>
  <result pre="similar to those previously identified for distantly related flaviviruses, including" exact="Zika" post="(23), DEN (40, 41), and YF (22) viruses. Especially"/>
  <result pre="from other flaviviruses, included an α-helix that is absent from" exact="Zika" post="and DEN viruses. Its protrusion from the upper part"/>
  <result pre="in other clinically relevant flaviviruses, including yellow fever, dengue and" exact="Zika" post="viruses. Together, these data provide novel insights into a"/>
  <result pre="development. Viruses. (2019) 11:E823. 10.3390/v1109082331491885 2.AberleSWKolodziejekJJungbauerCStiasnyKAberleJHZoufalyAet al.. Increase in human" exact="West Nile" post="and Usutu virus infections, Austria, 2018. Eurosurveillance. (2018) 23:7–12."/>
  <result pre="Usutu virus infections, Austria, 2018. Eurosurveillance. (2018) 23:7–12. 10.2807/1560-7917.ES.2018.23.43.180054530376913 3.BarrettADT." exact="West Nile" post="in Europe: an increasing public health problem. J Travel"/>
  <result pre="public health problem. J Travel Med. (2018) 25:1–2. 10.1093/jtm/tay09630289526 4.GouldLHFikrigE." exact="West Nile" post="virus: a growing concern?J Clin Invest. (2004) 113:1102–7. 10.1172/JCI2162315085186"/>
  <result pre="8, 2019). 6.DiamondMSPiersonTCFremontDH. The structural immunology of antibody protection against" exact="West Nile" post="virus. Immunol Rev. (2008) 225:212–25. 10.1111/j.1600-065X.2008.00676.x18837784 7.MehlhopEDiamondMS. The molecular"/>
  <result pre="225:212–25. 10.1111/j.1600-065X.2008.00676.x18837784 7.MehlhopEDiamondMS. The molecular basis of antibody protection against" exact="West Nile" post="Virus. Hum Antibody Therapeut Viral Disease. (2008) 317:125–53. 10.1007/978-3-540-72146-8_517990792"/>
  <result pre="for vaccine development. Cell Host Microbe. (2008) 4:229–38. 10.1016/j.chom.2008.08.00418779049 9.BrienJDUhrlaubJLNikolich-ZugichJ." exact="West Nile" post="virus-specific CD4 T cells exhibit direct antiviral cytokine secretion"/>
  <result pre="10.4049/jimmunol.181.12.856819050276 10.SitatiEMDiamondMS. CD4(+) T-cell responses are required for clearance of" exact="West Nile" post="virus from the central nervous system. J Virol. (2006)"/>
  <result pre="on the dominance of virus-specific CD4 T cell epitopes in" exact="Zika" post="virus infection. Front Immunol. (2018) 9:208310.3389/fimmu.2018.0208330254648 24.SchwaigerJAberleJHStiasnyKKnappBSchreinerWFaeIet al.. Specificities"/>
  <result pre="J Virol. (2014) 88:7828–42. 10.1128/JVI.00196-1424789782 25.KanaiRKarKAnthonyKGouldLHLedizetMFikrigEet al.. Crystal structure of" exact="West Nile" post="virus envelope glycoprotein reveals viral surface epitopes. J Virol."/>
  <result pre="(1995) 375:291–8. 10.1038/375291a07753193 31.StiasnyKAberleSWHeinzFX. Retrospective identification of human cases of" exact="West Nile" post="virus infection in Austria (2009 to 2010) by serological"/>
  <result pre="RT-PCR assay for detection and quantification of both lineages of" exact="West Nile" post="virus RNA. J Clin Virol. (2006) 36:177–82. 10.1016/j.jcv.2006.02.00816675298 33.NybakkenGEOliphantTJohnsonSBurkeSDiamondMSFremontDH."/>
  <result pre="J Clin Virol. (2006) 36:177–82. 10.1016/j.jcv.2006.02.00816675298 33.NybakkenGEOliphantTJohnsonSBurkeSDiamondMSFremontDH. Structural basis of" exact="West Nile" post="virus neutralization by a therapeutic antibody. Nature. (2005) 437:764–8."/>
  <result pre="to tick-borne encephalitis vaccination. NPJ Vaccines. (2019) 4:38. 10.1038/s41541-019-0133-531508246 36.DoklandTWalshMMackenzieJMKhromykhAAEeKHWangS." exact="West Nile" post="virus core protein; tetramer structure and ribbon formation. Structure."/>
  <result pre="7:539. 10.1038/msb.2011.7521988835 44.SirohiDChenZGSunLKloseTPiersonTCRossmannMGet al.The 3.8 angstrom resolution cryo-EM structure of" exact="Zika" post="virus. Science. (2016) 352:467–70. 10.1126/science.aaf531627033547 45.AngeloMAGrifoniAO'RourkePHSidneyJPaulSPetersBet al.. Human CD4(+)"/>
  <result pre="in proteins. Embo J. (1986) 5:823–6. 10.1002/j.1460-2075.1986.tb04288.x3709526 60.JamesEAGatesTJLaFondREYamamotoSNiCMaiDet al.. Neuroinvasive" exact="West Nile" post="infection elicits elevated and atypically polarized t cell responses"/>
  <result pre="Development of a humanized monoclonal antibody with therapeutic potential against" exact="West Nile" post="virus. Nat Med. (2005) 11:522–30. 10.1038/nm124015852016 67.KaufmannBVogtMRGoudsmitJHoldawayHAAksyukAAChipmanPRet al.. Neutralization"/>
  <result pre="virus. Nat Med. (2005) 11:522–30. 10.1038/nm124015852016 67.KaufmannBVogtMRGoudsmitJHoldawayHAAksyukAAChipmanPRet al.. Neutralization of" exact="West Nile" post="virus by cross-linking of its surface proteins with Fab"/>
  <result pre="Nat Med. (2015) 21:1216–22. 10.1038/nm.395826413780 73.MurrayKWalkerCHerringtonELewisJAMcCormickJBeasleyDWCet al.. Persistent Infection with" exact="West Nile" post="Virus Years after Initial Infection. J Infect Diseases. (2010)"/>
  <result pre="201:2–4. 10.1086/64873119961306 74.LanteriMCO'BrienKMPurthaWECameronMJLundJMOwenREet al.. Tregs control the development of symptomatic" exact="West Nile" post="virus infection in humans and mice. J Clin Invest."/>
  <result pre="Genetic contribution of MHC Class II genes in susceptibility to" exact="West Nile" post="virus infection. PLoS ONE. (2016) 11:e165952. 10.1371/journal.pone.016595227812212 77.SarriCAPapadopoulosGEPapaATsakrisAPervanidouDBakaAet al.."/>
  <result pre="class II peptide-binding region associated with protection/susceptibility to the severe" exact="West Nile" post="Virus disease. PLoS ONE. (2018) 13:e205557. 10.1371/journal.pone.020555730379846 Abbreviations C"/>
  <result pre="disease. PLoS ONE. (2018) 13:e205557. 10.1371/journal.pone.020555730379846 Abbreviations C capsid DEN" exact="Dengue" post="E envelope HLA human leukocyte antigen JE Japanese encephalitis"/>
  <result pre="peripheral blood mononuclear cells prM pre-membrane TBE Tick-borne encephalitis WN" exact="West Nile" post="WND West Nile virus disease YF Yellow fever."/>
  <result pre="cells prM pre-membrane TBE Tick-borne encephalitis WN West Nile WND" exact="West Nile" post="virus disease YF Yellow fever."/>
  <result pre="encephalitis WN West Nile WND West Nile virus disease YF" exact="Yellow fever." post=""/>
 </snippets>
</snippetsTree>
